Acadia Pharmaceuticals (ACAD) Intangibles (2016 - 2026)
Acadia Pharmaceuticals (ACAD) posted Intangibles of $103.45 million for Q2 2026, down 9.5% from $114.34 million a year earlier and down 2.6% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Intangibles (2016 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals' Intangibles came in at $108.89 million, down 9.1% from FY2024.
- Annual Intangibles shows a five-year compound annual growth rate of 150.3% (FY2020 to FY2025).
- In prior years, Acadia Pharmaceuticals' Intangibles was $119.78 million in FY2024 (+82.9%) and $65.49 million in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Intangibles since Q4 2023.
- On a year-over-year basis, Intangibles has declined in each of the last three quarters, with growth averaging 16.4% over the last eight quarters.
- The strongest year-over-year quarter for Intangibles in the past five years was Q4 2024, with growth of 82.9%; the weakest was Q2 2026, with a decline of 9.5%.
- According to Business Quant data, Intangibles for the three prior quarters was $106.17 million (Q1 2026), $108.89 million (Q4 2025) and $111.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Acadia Pharmaceuticals | 2.95 Bn | -526.50 Mn | 279.64 Mn | 103.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.45 Mn |
| Mar 31, 2026 | 106.17 Mn |
| Dec 31, 2025 | 108.89 Mn |
| Sep 30, 2025 | 111.62 Mn |
| Jun 30, 2025 | 114.34 Mn |
| Mar 31, 2025 | 117.06 Mn |
| Dec 31, 2024 | 119.78 Mn |
| Sep 30, 2024 | 105.52 Mn |
| Jun 30, 2024 | 107.86 Mn |
| Mar 31, 2024 | 110.20 Mn |
| Dec 31, 2023 | 65.49 Mn |
| Sep 30, 2023 | 66.86 Mn |
| Jun 30, 2023 | 68.22 Mn |
| Mar 31, 2023 | 69.58 Mn |
| Jun 30, 2021 | 369,000.00 |
| Mar 31, 2021 | 738,000.00 |
| Dec 31, 2020 | 1.11 Mn |
| Sep 30, 2020 | 1.48 Mn |
| Jun 30, 2020 | 1.85 Mn |
| Mar 31, 2020 | 2.22 Mn |
API Access
Acadia Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();